Compare TWST & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | PEB |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2018 | 2009 |
| Metric | TWST | PEB |
|---|---|---|
| Price | $46.04 | $11.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 10 |
| Target Price | ★ $47.89 | $12.35 |
| AVG Volume (30 Days) | 1.4M | ★ 2.3M |
| Earning Date | 02-02-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 0.35% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $391,557,000.00 | ★ $1,464,126,000.00 |
| Revenue This Year | $16.77 | $2.11 |
| Revenue Next Year | $15.06 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.59 | 0.99 |
| 52 Week Low | $23.30 | $7.42 |
| 52 Week High | $54.74 | $12.95 |
| Indicator | TWST | PEB |
|---|---|---|
| Relative Strength Index (RSI) | 69.16 | 44.75 |
| Support Level | $39.66 | $11.26 |
| Resistance Level | $43.34 | $12.79 |
| Average True Range (ATR) | 2.50 | 0.38 |
| MACD | 0.16 | -0.10 |
| Stochastic Oscillator | 77.41 | 11.76 |
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.